NCT05171621 (MQUEST) is a clinical trial in Ophthalmologic Complication, sponsored by Hayley Westwood.

Who is sponsoring NCT05171621?

NCT05171621 is sponsored by Hayley Westwood.

What condition does NCT05171621 study?

NCT05171621 studies Ophthalmologic Complication, Epiretinal Membrane, Metamorphopsia, Macular Holes.

Is NCT05171621 still recruiting?

NCT05171621 is currently completed. Last updated 29 December 2021.

Last reviewed 2021-12-29 · How we verify

NCT05171621: MQUEST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery

Completed Last updated 29 December 2021

What this trial tests

trial in Ophthalmologic Complication in 50 participants. Completed in 31 October 2021.

Timeline

16 October 2019

Primary endpoint
31 October 2021

31 October 2021

Quick facts

Lead sponsor	Hayley Westwood
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	16 October 2019
Primary completion	31 October 2021
Estimated completion	31 October 2021
Sites	1 location across United Kingdom

Conditions studied

Ophthalmologic Complication — all drugs for Ophthalmologic Complication →
Epiretinal Membrane — all drugs for Epiretinal Membrane →
Metamorphopsia — all drugs for Metamorphopsia →
Macular Holes — all drugs for Macular Holes →

Sponsor

Hayley Westwood

Who can join

18 and older, any sex, with Ophthalmologic Complication or Epiretinal Membrane. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessing metamorphopsia and quality of vision pre and post epiretinal and macular hole surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05171621 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hayley Westwood
Last refreshed: 29 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05171621.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing